Authors
Latest:
High-resolution multimodal imaging is key in dry AMD therapeutic development, future managementIn an attempt to halt the progression of dry AMD and geographic atrophy, the use of high-resolution optical coherence tomography becomes pivotal.
Latest:
Effectiveness Of Pegcetacoplan In Preserving Visual Function In Geographic AtrophyDr Charles Wykoff presents the results of a post hoc microperimetry analysis from the OAKS study demonstrating the effectiveness of pegcetacoplan in preserving visual function.
Latest:
Clinical Implications of Port Delivery System in Retinal DiseasesClosing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.
Latest:
Vitrectomy: Is higher speed always better?Physicians should consider hydrodynamic cavitation when performing this procedure.
Latest:
Poll: Most anticipated emerging therapies in neovascular AMD and DMEA panel of retina specialists review new and emerging treatments in neovascular AMD and DME, highlighting high-dose aflibercept and KSI-301. Which emerging treatments are you most interested in?
Latest:
Pearls for maintaining quality, safety in retina clinics amid a pandemicTo maintain treatment quality and patient and staff safety in the SARS-CoV-2 era, it is important to minimize clinic visits and maximize the use of imaging modalities. In addition, extending treatment intervals with longer-acting agents is key to maximizing safety and patients’ vision outcomes.
Latest:
ASRS 2024: Real-world efficacy and safety of aflibercept 8 mg in neovascular AMDDeepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Latest:
Setting a New Standard in Automated Tracked PerimetryInnovative new features build on the benefits of the iCare COMPASS Automated Perimeter
Latest:
A case of a 79-year-old pseudophakic patient with AMD and rapidly progressing GAThe final case is presented by Dr Adam, showcasing a 79-year old patient with multiple diagnoses and rapid progression of geographic atrophy.
Latest:
CTS 2024: Considering structural and functional biomarkers in dry AMDEleonora Lad, MD, PhD, discusses the stages of dry AMD from early to intermediate to geographic atrophy, while also assessing which endpoints are most useful for these different stages.
Latest:
Ophthalmologist shares his story on Holocaust Remembrance DayJohn H. Merey, MD, possibly one of the last Holocaust survivors still in the practice of ophthalmology, shares his story.
Latest:
Searching for durable therapies for diabetic macular edema amid the pandemicPatients’ reluctance to visit a clinic during the COVID-19 pandemic is pushing retina specialists to optimize therapy.
Latest:
Optimizing Care For Patients With Retinal DisordersKey takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.
Latest:
Exploring cryopreserved amniotic membrane following intravitreal injectionCAM encourages corneal healing in patients with ocular surface disease.
Latest:
Sustained-release anti-inflammatory therapy is valuable in noninfectious uveitisLong-term sustained-release therapy pays off in management of chronic, vision-threatening disease.
Latest:
Implementing Higher Molar Dose in Your Clinical PracticeJohn Kitchens, MD, and Peter Kaiser, MD, discuss drug duration, accelerating dosing intervals, and other pearls for aflibercept dosing in wet AMD.
Latest:
DR/DME: Ongoing Clinical Trials and New Diagnostic ToolsCarolyn Majcher, OD, FAAO, and Rishi Singh, MD, discuss new and upcoming clinical trials, investigational therapies, and diagnostic tools for the treatment of diabetic retinopathy and diabetic macular edema (DR/DME).
Latest:
Broadening the benefits of iCare EIDON retinal imaging with the new Ultra-Wide Field ModuleThis article is produced by iCare Finland for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.
Latest:
Successful treatment of bilateral diffuse Uveal melanocytic proliueration with plasmapheresisNonetheless,BDUMP remains a rare condition with fewer than 60 cases documented in literature.
Latest:
IOL designed for AMD offers hope for patientsExamining an intraocular implant that can sharpen vision for patients as disease progresses.
Latest:
Creating the best care environment for patients with diabetic eye diseaseTunde Peto, MD, PhD, discusses her presentation on providing the best virtual care for patients with diabetic eye disease at EURETINA 2021.
Latest:
Why wait? The data show administering steroids to DME patients with good vision leads to long-term successA review of the phase 4 PALADIN data show that steroid-eluting implants lead to good vision, safe outcomes, and reduced burden in patients with DME.
Latest:
Saving the world: Pharmaceutical innovation in nine monthsThe COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.
Latest:
Optimizing Care For Patients With Retinal DisordersKey takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.
Latest:
Patient Cases Demonstrating the Application of Treat and Extend Algorithm for Faricimab in DMEDr Jennifer Lim presents two case studies demonstrating the application of the personalized treatment interval algorithm from the YOSEMITE and RHINE clinical trials for faricimab in DME.
Latest:
Using virtual reality mobility testing as a standardized clinical end point in inherited retinal disordersThe use of VR mazes hold an intrinsic advantage compared with physical mazes in the ability to control conditions and test various patterns with reliability, participant safety, and repeatability.
Latest:
Microaneurysm turnover predicts diabetic retinopathy progressionMicoaneurysm turnover in the early stages of diabetic retinopathy predicts how much the disease will progress, according to researchers.
Latest:
Electroretinography: Out of the laboratory and into the clinicOCT has many benefits, yet falls short of reliably diagnosing and managing retinopathies and glaucoma. ERG remains the stalwart method for this application and this article highlights how technological advancements have enabled its introduction to the clinic.
